MedPath

French Travelers' Knowledge of Risk of Acquiring ESBL-PE

Completed
Conditions
Travel Medicine
Interventions
Other: Questionnaire
Registration Number
NCT03339947
Lead Sponsor
CHU de Reims
Brief Summary

Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, the investigators aimed to determine, among French travelers attending a consultation for travel medicine, patients level of knowledge about the risk of acquiring MRE.

Detailed Description

Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, The investigators aimed to assess, among persons attending a consultation for travel medicine and international vaccines, patients level of knowledge regarding the risk of acquiring MRE, preventive behaviours and the need to inform health professionals that they had recently travelled if the patients require medical care after their return. A cross-sectional study was performed in the consultation for travel medicine and international vaccination in Reims University Hospital, France. All adult travellers who attended this consultation between January 2016 and May 2016 and who completed the questionnaire were included in the study. The questionnaire was completed before the planned travel. The travellers answered the questionnaires before seeing the physician.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
191
Inclusion Criteria
  • Adult travellers who attended the consultation for travel medicine and international vaccination in Reims University Hospital
  • Adult who completed the questionnaire
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Travel medicineQuestionnaireAll adult travellers who attended the consultation for travel medicine and international vaccination in Reims University Hospital.
Primary Outcome Measures
NameTimeMethod
Level of knowledge regarding multidrug resistant EnterobacteriaceaeDay 1

The questionnaire was completed before the planned travel and recorded information on the patient's knowledge of the definition of multidrug resistant bacteria (MDR), knowledge of the factors associated with acquiring MDR bacteria, consumption of antibiotics during previous travel, awareness of the need to inform health professionals about the recent trip in case of health problems after return, perceived need for more information about MDR bacteria, desired source of such information. The questions about knowledge were designed to be as simple as possible, with closed answers ('yes', 'no', 'don't know')

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Damien JOLLY

🇫🇷

Reims, France

© Copyright 2025. All Rights Reserved by MedPath